Analysen von Richard Vosser
| 16.07.21 | Bayer Overweight | JP Morgan Chase & Co. | |
| 07.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.07.21 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 05.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.07.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 01.07.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.06.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.06.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.05.21 | Bayer overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 20.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 19.05.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.05.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.05.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 19.05.21 | Bayer overweight | JP Morgan Chase & Co. | |
| 13.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 12.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 12.05.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 05.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 04.05.21 | Merck overweight | JP Morgan Chase & Co. | |
| 30.04.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 28.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.21 | Merck overweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |